Rocket Pharmaceuticals Statistics

Total Valuation

RCKT has a market cap or net worth of $2.00 billion. The enterprise value is $1.65 billion.

Market Cap	2.00B
Enterprise Value	1.65B

Important Dates

The next estimated earnings date is Friday, May 10, 2024, after market close.

Earnings Date	May 10, 2024
Ex-Dividend Date	n/a

Share Statistics

RCKT has 90.50 million shares outstanding. The number of shares has increased by 23.27% in one year.

Shares Outstanding	90.50M
Shares Change (YoY)	+23.27%
Shares Change (QoQ)	+13.07%
Owned by Insiders (%)	3.68%
Owned by Institutions (%)	101.42%
Float	70.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.06
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.80, with a Debt / Equity ratio of 0.05.

Current Ratio	7.80
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-129.98

Financial Efficiency

Return on equity (ROE) is -51.80% and return on invested capital (ROIC) is -50.16%.

Return on Equity (ROE)	-51.80%
Return on Assets (ROA)	-45.90%
Return on Capital (ROIC)	-50.16%
Revenue Per Employee	n/a
Profits Per Employee	-$916,399
Employee Count	268
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.37% in the last 52 weeks. The beta is 1.06, so RCKT's price volatility has been similar to the market average.

Beta (1Y)	1.06
52-Week Price Change	+24.37%
50-Day Moving Average	26.75
200-Day Moving Average	23.07
Relative Strength Index (RSI)	31.92
Average Volume (30 Days)	717,617

Short Selling Information

The latest short interest is 11.00 million, so 12.16% of the outstanding shares have been sold short.

Short Interest	11.00M
Short Previous Month	10.52M
Short % of Shares Out	12.16%
Short % of Float	15.50%
Short Ratio (days to cover)	16.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-259.66M
Pretax Income	-245.60M
Net Income	-245.60M
EBITDA	-236.62M
EBIT	-243.72M
Earnings Per Share (EPS)	-$2.92

Full Income Statement

Balance Sheet

The company has $375.08 million in cash and $25.04 million in debt, giving a net cash position of $350.04 million or $3.87 per share.

Cash & Cash Equivalents	375.08M
Total Debt	25.04M
Net Cash	350.04M
Net Cash Per Share	$3.87
Equity / Book Value	492.57M
Book Value Per Share	5.44
Working Capital	329.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$194.92 million and capital expenditures -$16.47 million, giving a free cash flow of -$211.39 million.

Operating Cash Flow	-194.92M
Capital Expenditures	-16.47M
Free Cash Flow	-211.39M
FCF Per Share	-$2.52

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.27%
Shareholder Yield	-23.27%
Earnings Yield	-12.28%
FCF Yield	-10.57%

Dividend Details

Analyst Forecast

The average price target for RCKT is $51.70, which is 133.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$51.70
Price Target Difference	133.94%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 5, 2018. It was a reverse split with a ratio of 1:4.

Last Split Date	Jan 5, 2018
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1